Jasper Therapeutics's total assets for Q1 2026 were $21.18M, a decrease of -40.79% from the previous quarter. JSPR total liabilities were $17.78M for the fiscal quarter, a -43.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.